β-Amyrin palmitate

β-Amyrin palmitate shows HMG-CoA reductase inhibition[1]. And β-Amyrin palmitate has anti-diabetes mellitus activity[2].

Product Specifications

CAS Number

[5973-06-8]

UNSPSC

12352211

Hazard Statement

H302, H371

Target

HMG-CoA Reductase (HMGCR)

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Cardiovascular Disease; Endocrinology

Assay Protocol

https://www.medchemexpress.com/β-amyrin-palmitate.html

Purity

98.0

Solubility

10 mM in DMSO

Smiles

C[C@]12[C@]3(C([C@@]4([H])[C@@](CC3)(CCC(C)(C4)C)C)=CC[C@]1([H])[C@@]5([C@@](C(C)([C@H](CC5)OC(CCCCCCCCCCCCCCC)=O)C)([H])CC2)C)C

Molecular Formula

C46H80O2

Molecular Weight

665.13

Precautions

H302, H371

References & Citations

[1]Maurya R, et al. β-Amyrin acetate and β-amyrin palmitate as antidyslipidemic agents from Wrightia tomentosa leaves. Phytomedicine. 2012;19 (8-9) :682-685.|[2]Nair SA, et al. Promising anti-diabetes mellitus activity in rats of β-amyrin palmitate isolated from Hemidesmus indicus roots. Eur J Pharmacol. 2014;734:77-82.